Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Thomas SE, Seyger MMB, Mangnus JE, Otero ME, Gostynski AH, Njoo MD, Ossenkoppele PM, Haeck IM, Hendricksen-Roelofzen JHJ, Körver JEM, Dodemont SRP, Tupker RA, Berends MAM, Weppner-Parren LMJT, Keijsers RRMC, Oostveen AM, Peters B, Mommers R, van Doorn MBA, Tjioe M, Veldkamp WR, Kuijpers ALA, Kleinpenning MM, de Jong EMGJ, van den Reek JMPA. Thomas SE, et al. Among authors: van den reek jmpa. Am J Clin Dermatol. 2024 May 27. doi: 10.1007/s40257-024-00868-x. Online ahead of print. Am J Clin Dermatol. 2024. PMID: 38802618 No abstract available.
Dose reduction of biologics in patients with plaque psoriasis: a review.
van Riel CAM, Michielsens CAJ, van Muijen ME, van der Schoot LS, van den Reek JMPA, de Jong EMGJ. van Riel CAM, et al. Among authors: van den reek jmpa. Front Pharmacol. 2024 Mar 28;15:1369805. doi: 10.3389/fphar.2024.1369805. eCollection 2024. Front Pharmacol. 2024. PMID: 38606178 Free PMC article. Review.
The lifestyle of psoriasis patients and their motivation to change.
Al-Gawahiri M, van den Reek JMPA, van Acht MR, Evers AWM, de Jong EMGJ, Seyger MMB. Al-Gawahiri M, et al. Among authors: van den reek jmpa. J Eur Acad Dermatol Venereol. 2024 Feb 24. doi: 10.1111/jdv.19923. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38400656 No abstract available.
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.
van Hal TW, van den Reek JMPA, Wenink MH, Otero ME, Ossenkoppele PM, Njoo MD, Oostveen A, Peters B, Tjioe M, Kop EN, Körver JEM, Dodemont SRP, Kleinpenning MM, Berends MAM, Veldkamp WR, van Doorn MBA, Mommers JM, Lindhout RJ, Kuijpers ALA, van Lümig PP, de Jonge CEJ, Tupker RA, Hendricksen J, Keijsers RR, van den Hoogen FHJ, Vriezekolk JE, de Jong EMGJ. van Hal TW, et al. Among authors: van den reek jmpa. J Dermatolog Treat. 2024 Dec;35(1):2304025. doi: 10.1080/09546634.2024.2304025. Epub 2024 Jan 23. J Dermatolog Treat. 2024. PMID: 38263716 Free article.
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks.
Ter Haar ELM, Van den Reek JMPA, Gaarn Du Jardin K, Barbero-Castillo A, De Jong EMGJ, Lubeek SFK. Ter Haar ELM, et al. Among authors: van den reek jmpa. Acta Derm Venereol. 2023 Oct 25;103:adv17752. doi: 10.2340/actadv.v103.17752. Acta Derm Venereol. 2023. PMID: 37877618 Free PMC article. Clinical Trial.
85 results